Amino acid supplement could slow vision loss in rare eye disease
Disease control
Not yet recruiting
This Phase 3 study tests whether taking serine, a natural amino acid, twice daily for 24 months can slow vision loss in people with MacTel type 2, a rare eye disease that damages the retina. About 120 adults will receive either serine or a placebo. Researchers will track retinal …
Phase: PHASE3 • Sponsor: The Lowy Medical Research Institute Limited • Aim: Disease control
Last updated May 15, 2026 08:53 UTC